FLASH Radiotherapy Mitigates Radiation-Induced Lymphopenia and Prevents Immunosuppression via Chk1-STAT3 Axis Modulation in a Preclinical Thoracic Irradiation Model
- 22 April 2026
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 126 (3) , 808-820
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Cancer Prevention and Research Institute of Texas (RP210042)
This publication has 77 references indexed in Scilit:
- Development of novel ionization chambers for reference dosimetry in electron flash radiotherapyMedical Physics, 2024
- Technical note: High‐dose and ultra‐high dose rate (UHDR) evaluation of Al2O3:C optically stimulated luminescent dosimeter nanoDots and powdered LiF:Mg,Ti thermoluminescent dosimeters for radiation therapy applicationsMedical Physics, 2023
- Comprehensive evaluation and new recommendations in the use of Gafchromic EBT3 filmMedical Physics, 2023
- Dual beam‐current transformer design for monitoring and reporting of electron ultra‐high dose rate (FLASH) beam parametersJournal of Applied Clinical Medical Physics, 2023
- Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone MetastasesJAMA Oncology, 2023
- Ultra‐high dose rate electron beams and the FLASH effect: From preclinical evidence to a new radiotherapy paradigmMedical Physics, 2022
- Radiobiology of the FLASH effectMedical Physics, 2021
- Does FLASH deplete oxygen? Experimental evaluation for photons, protons, and carbon ionsMedical Physics, 2021
- Commissioning of an ultra‐high dose rate pulsed electron beam medical LINAC for FLASH RT preclinical animal experiments and future clinical human protocolsMedical Physics, 2021
- Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responsesEuropean Journal of Immunology, 2003